Spinal cord injury (SCI) results in an array of debilitating, sometimes permanent—and at times life-threatening—motor, sensory, and autonomic deficits. A broad range of therapies have been tested pre-clinically, and there has been a significant acceleration in recent years of clinical translation of potential treatments. However, it is widely appreciated among scientists and clinical professionals alike that there likely is no “silver bullet” (single treatment) that will result in complete functional restoration after SCI. The combination of more than one treatment approach, especially treatments that can have distinct beneficial effects, increases the probability of functional improvement. This review highlights the mounting interest in the pre-clinical development and application of combination strategies to treat SCI, and some of the translational efforts made to combine promising therapies for clinical evaluation. Special attention is given to barriers and limitations faced in translating treatments for people living with SCI.
GriffinJM, BradkeF. Therapeutic repair for spinal cord injury: Combinatory approaches to address a multifaceted problem. EMBO Mol Med, 2020; 12(3):e11505; doi: 10.15252/emmm.201911505
2.
AustinJW, RowlandJW, FehlingsMG, et al.Pathophysiology of spinal cord injury. In: Essentials of Spinal Cord Injury: Basic Research to Clinical Practice. (FehlingsMG, VaccaroAR, BoakyeM, eds.) Thieme Medical Publishers, Inc.: New York; 2013.
3.
SeifM, DavidG, HuberE, et al.Cervical cord neurodegeneration in traumatic and non-traumatic spinal cord injury. J Neurotrauma, 2020; 37(6):860–867; doi: 10.1089/neu.2019.6694
4.
SeidenwurmDJ. Expert panel on neurologic I. myelopathy. AJNR Am J Neuroradiol, 2008; 29(5):1032–1034.
5.
CourtineG, SofroniewMV. Spinal cord repair: Advances in biology and technology. Nat Med, 2019; 25(6):898–908; doi: 10.1038/s41591-019-0475-6
6.
DonnellyDJ, PopovichPG. Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury. Exp Neurol, 2008; 209(2):378–388; doi: 10.1016/j.expneurol.2007.06.009
7.
FilousAR, SchwabJM. Determinants of axon growth, plasticity, and regeneration in the context of spinal cord injury. Am J Pathol, 2018; 188(1):53–62; doi: 10.1016/j.ajpath.2017.09.005
8.
MiclauTA, Torres-EspinA, MorshedS, et al.; Transforming Research and Clinical Knowledge in Spinal Cord Injury (TRACK-SCI) Investigators. Appendicular fracture and polytrauma correlate with outcome of spinal cord injury: A transforming research and clinical knowledge in spinal cord injury study. J Neurotrauma, 2022; 39(15–16):1030–1038; doi: 10.1089/neu.2021.0375
9.
CreaseyGH, LatevaZC, SchusslerFIORENZA, et al.Traumatic brain injury in U.S. Veterans with traumatic spinal cord injury. J Rehabil Res Dev, 2015; 52(6):669–676; doi: 10.1682/JRRD.2014.11.0291
10.
InoueT, LinA, MaX, et al.Combined SCI and TBI: Recovery of forelimb function after unilateral cervical spinal cord injury (SCI) is retarded by contralateral traumatic brain injury (TBI), and ipsilateral TBI balances the effects of SCI on paw placement. Exp Neurol, 2013; 248:136–147; doi: 10.1016/j.expneurol.2013.06.006
11.
BurnsAS, MarinoRJ, Kalsi-RyanS, et al.Type and timing of rehabilitation following acute and subacute spinal cord injury: A systematic review. Global Spine J, 2017; 7(Suppl 3):175S–194S; doi: 10.1177/2192568217703084
12.
WarrenPM, TranAP, SilverJ. Perspectives on “the biology of spinal cord regeneration success and failure. Neural Regen Res, 2018; 13(8):1358–1359; doi: 10.4103/1673-5374.235226
13.
ReierPJ, ZholudevaLV, LaneMA. Axonal degeneration and regeneration in the peripheral and central nervous systems. In: Conn’s Translational Neuroscience, 2017:553–575.
14.
KwonBK, OxlandTR, TetzlaffW. Animal models used in spinal cord regeneration research. Spine (Phila Pa 1976), 2002; 27(14):1504–1510.
15.
KwonBK, StreijgerF, HillCE, et al.Large animal and primate models of spinal cord injury for the testing of novel therapies. Exp Neurol, 2015; 269:154–168; doi: 10.1016/j.expneurol.2015.04.008
16.
LeeJH, JonesCF, OkonEB, et al.A novel porcine model of traumatic thoracic spinal cord injury. J Neurotrauma, 2013; 30(3):142–159; doi: 10.1089/neu.2012.2386
17.
StreijgerF, BeerninkTM, LeeJH, et al.Characterization of a cervical spinal cord hemicontusion injury in mice using the infinite horizon impactor. J Neurotrauma, 2013; 30(10):869–883; doi: 10.1089/neu.2012.2405
18.
JefferyND, SmithPM, LakatosA, et al.Clinical canine spinal cord injury provides an opportunity to examine the issues in translating laboratory techniques into practical therapy. Spinal Cord, 2006; 44(10):584–593; doi: 10.1038/sj.sc.3101912
19.
ScheffSW, RabchevskyAG, FugacciaI, et al.Experimental modeling of spinal cord injury: Characterization of a force-defined injury device. J Neurotrauma, 2003; 20(2):179–193; doi: 10.1089/08977150360547099
20.
FryEJ, StolpHB, LaneMA, et al.Regeneration of supraspinal axons after complete transection of the thoracic spinal cord in neonatal opossums (Monodelphis domestica). J Comp Neurol, 2003; 466(3):422–444; doi: 10.1002/cne.10904
21.
LaneMA, TruettnerJS, BrunschwigJP, et al.Age-related differences in the local cellular and molecular responses to injury in developing spinal cord of the opossum, Monodelphis domestica. Eur J Neurosci, 2007; 25(6):1725–1742; doi: 10.1111/j.1460-9568.2007.05439.x
22.
KutikovAB, MooreSW, LayerRT, et al.Method and Apparatus for the Automated Delivery of Continuous Neural Stem Cell Trails Into the Spinal Cord of Small and Large Animals. Neurosurgery, 2019; 85(4):560–573; doi: 10.1093/neuros/nyy379
23.
SantamariaAJ, BenavidesFD, PadgettKR, et al.Dichotomous locomotor recoveries are predicted by acute changes in segmental blood flow after thoracic spinal contusion injuries in pigs. J Neurotrauma, 2019; 36(9):1399–1415; doi: 10.1089/neu.2018.6087
24.
PlemelJR, DuncanG, ChenKW, et al.A graded forceps crush spinal cord injury model in mice. J Neurotrauma, 2008; 25(4):350–370; doi: 10.1089/neu.2007.0426
25.
ChooAM, LiuJ, LiuZ, et al.Modeling spinal cord contusion, dislocation, and distraction: Characterization of vertebral clamps, injury severities, and node of Ranvier deformations. J Neurosci Methods, 2009; 181(1):6–17; doi: 10.1016/j.jneumeth.2009.04.007
26.
JakemanLB, GuanZ, WeiP, et al.Traumatic spinal cord injury produced by controlled contusion in mouse. J Neurotrauma, 2000; 17(4):299–319; doi: 10.1089/neu.2000.17.299
27.
StokesBT, JakemanLB. Experimental modelling of human spinal cord injury: A model that crosses the species barrier and mimics the spectrum of human cytopathology. Spinal Cord, 2002; 40(3):101–109; doi: 10.1038/sj.sc.3101254
MooreSA, GrangerN, OlbyNJ, et al.Targeting translational successes through CANSORT-SCI: Using pet dogs to identify effective treatments for spinal cord injury. J Neurotrauma, 2017; 34(12):2007–2018; doi: 10.1089/neu.2016.4745
30.
de LeonRD, HodgsonJA, RoyRR, et al.Retention of hindlimb stepping ability in adult spinal cats after the cessation of step training. J Neurophysiol, 1999; 81(1):85–94.
31.
de LeonRD, HodgsonJA, RoyRR, et al.Locomotor capacity attributable to step training versus spontaneous recovery after spinalization in adult cats. J Neurophysiol, 1998; 79(3):1329–1340.
32.
DaiH, MacarthurL, McAteeM, et al.Delayed rehabilitation with task-specific therapies improves forelimb function after a cervical spinal cord injury. Restor Neurol Neurosci, 2011; 29(2):91–103; doi: 10.3233/RNN-2011-0583
33.
FouadK, TetzlaffW. Rehabilitative training and plasticity following spinal cord injury. Exp Neurol, 2012; 235(1):91–99; doi: 10.1016/j.expneurol.2011.02.009
34.
van den BrandR, HeutschiJ, BarraudQ, et al.Restoring voluntary control of locomotion after paralyzing spinal cord injury. Science, 2012; 336(6085):1182–1185; doi: 10.1126/science.1217416
35.
LuP, FreriaCM, GrahamL, et al.Rehabilitation combined with neural progenitor cell grafts enables functional recovery in chronic spinal cord injury. JCI Insight, 2022; 7(16):e158000; doi: 10.1172/jci.insight.158000
36.
PieczonkaK, FehlingsMG. Incorporating combinatorial approaches to encourage targeted neural stem/progenitor cell integration following transplantation in spinal cord injury. Stem Cells Transl Med, 2023; 12(4):207–214; doi: 10.1093/stcltm/szad008
37.
TheisenCC, SachdevaR, AustinS, et al.Exercise and peripheral nerve grafts as a strategy to promote regeneration after acute or chronic spinal cord injury. J Neurotrauma, 2017; 34(10):1909–1914; doi: 10.1089/neu.2016.4640
38.
SachdevaR, TheisenCC, NinanV, et al.Exercise dependent increase in axon regeneration into peripheral nerve grafts by propriospinal but not sensory neurons after spinal cord injury is associated with modulation of regeneration-associated genes. Exp Neurol, 2016; 276:72–82; doi: 10.1016/j.expneurol.2015.09.004
39.
DelarueQ, RobacA, MassardierR, et al.Comparison of the effects of two therapeutic strategies based on olfactory ensheathing cell transplantation and repetitive magnetic stimulation after spinal cord injury in female mice. J Neurosci Res, 2021; 99(7):1835–1849; doi: 10.1002/jnr.24836
40.
PetrosyanHA, AlessiV, HunanyanAS, et al.Spinal electro-magnetic stimulation combined with transgene delivery of neurotrophin NT-3 and exercise: Novel combination therapy for spinal contusion injury. J Neurophysiol, 2015; 114(5):2923–2940; doi: 10.1152/jn.00480.2015
41.
MaierIC, IchiyamaRM, CourtineG, et al.Differential effects of anti-Nogo-A antibody treatment and treadmill training in rats with incomplete spinal cord injury. Brain, 2009; 132(Pt 6):1426–1440; doi: 10.1093/brain/awp085
42.
JakemanLB, HoschouerEL, BassoDM. Injured mice at the gym: Review, results and considerations for combining chondroitinase and locomotor exercise to enhance recovery after spinal cord injury. Brain Res Bull, 2011; 84(4–5):317–326; doi: 10.1016/j.brainresbull.2010.06.002
43.
Sakiyama-ElbertS, JohnsonPJ, HodgettsSI, et al.Scaffolds to promote spinal cord regeneration. Handb Clin Neurol, 2012; 109:575–594; doi: 10.1016/B978-0-444-52137-8.00036-X
44.
FuhrmannT, TamRY, BallarinB, et al.Injectable hydrogel promotes early survival of induced pluripotent stem cell-derived oligodendrocytes and attenuates longterm teratoma formation in a spinal cord injury model. Biomaterials, 2016; 83:23–36; doi: 10.1016/j.biomaterials.2015.12.032
45.
CoteMP, AminAA, TomVJ, et al.Peripheral nerve grafts support regeneration after spinal cord injury. Neurotherapeutics, 2011; 8(2):294–303; doi: 10.1007/s13311-011-0024-6
46.
LacroixS, TuszynskiMH. Neurotrophic factors and gene therapy in spinal cord injury. Neurorehabil Neural Repair, 2000; 14(4):265–275; doi: 10.1177/154596830001400403
47.
BradburyEJ, MoonLD, PopatRJ, et al.Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature, 2002; 416(6881):636–640.
48.
MasseyJM, HubscherCH, WagonerMR, et al.Chondroitinase ABC digestion of the perineuronal net promotes functional collateral sprouting in the cuneate nucleus after cervical spinal cord injury. J Neurosci, 2006; 26(16):4406–4414.
LiebscherT, SchnellL, SchnellD, et al.Nogo-A antibody improves regeneration and locomotion of spinal cord-injured rats. Ann Neurol, 2005; 58(5):706–719.
51.
AtwalJK, Pinkston-GosseJ, SykenJ, et al.PirB is a functional receptor for myelin inhibitors of axonal regeneration. Science, 2008; 322(5903):967–970; doi: 10.1126/science.1161151
52.
HallA, FortinoT, SpruanceV, et al.Cell transplantation to repair the injured spinal cord. Int Rev Neurobiol, 2022; 166:79–158; doi: 10.1016/bs.irn.2022.09.008
53.
BungeMB, MonjePV, KhanA, et al.From transplanting Schwann cells in experimental rat spinal cord injury to their transplantation into human injured spinal cord in clinical trials. Prog Brain Res, 2017; 231:107–133; doi: 10.1016/bs.pbr.2016.12.012
54.
PearseDD, SanchezAR, PereiraFC, et al.Transplantation of Schwann cells and/or olfactory ensheathing glia into the contused spinal cord: Survival, migration, axon association, and functional recovery. Glia, 2007; 55(9):976–1000; doi: 10.1002/glia.20490
55.
BartlettRD, PhillipsJB, ChoiD. Improved cell-purification techniques and safety monitoring needed for olfactory ensheathing cell transplantation. CMAJ, 2019; 191(43):E1199; doi: 10.1503/cmaj.73255
56.
BarbourHR, PlantCD, HarveyAR, et al.Tissue sparing, behavioral recovery, supraspinal axonal sparing/regeneration following sub-acute glial transplantation in a model of spinal cord contusion. BMC Neurosci, 2013; 14:106; doi: 10.1186/1471-2202-14-106
57.
RaismanG, BarnettSC, Ramon-CuetoA. Repair of central nervous system lesions by transplantation of olfactory ensheathing cells. Handb Clin Neurol, 2012; 109:541–549; doi: 10.1016/B978-0-444-52137-8.00033-4
58.
TakeokaA, JindrichDL, Munoz-QuilesC, et al.Axon regeneration can facilitate or suppress hindlimb function after olfactory ensheathing glia transplantation. J Neurosci, 2011; 31(11):4298–4310; doi: 10.1523/JNEUROSCI.4967-10.2011
TuszynskiMH, WangY, GrahamL, et al.Neural stem cells in models of spinal cord injury. Exp Neurol, 2014; 261:494–500; doi: 10.1016/j.expneurol.2014.07.011
61.
ZipserCM, CraggJJ, GuestJD, et al.Cell-based and stem-cell-based treatments for spinal cord injury: Evidence from clinical trials. Lancet Neurol, 2022; 21(7):659–670; doi: 10.1016/S1474-4422(21)00464-6
62.
McIntyreWB, PieczonkaK, KhazaeiM, et al.Regenerative replacement of neural cells for treatment of spinal cord injury. Expert Opin Biol Ther, 2021; 21(11):1411–1427; doi: 10.1080/14712598.2021.1914582
63.
RuffCA, WilcoxJT, FehlingsMG. Cell-based transplantation strategies to promote plasticity following spinal cord injury. Exp Neurol, 2012; 235(1):78–90; doi: 10.1016/j.expneurol.2011.02.010
64.
JagritV, KofflerJ, DulinJN. Combinatorial strategies for cell transplantation in traumatic spinal cord injury. Front Neurosci, 2024; 18:1349446; doi: 10.3389/fnins.2024.1349446
65.
RodemerW, GalloG, SelzerME. Mechanisms of axon elongation following CNS injury: What is happening at the axon tip? Front Cell Neurosci, 2020; 14:177; doi: 10.3389/fncel.2020.00177
66.
YickLW, WuW, SoKF, et al.Chondroitinase ABC promotes axonal regeneration of Clarke’s neurons after spinal cord injury. Neuroreport, 2000; 11(5):1063–1067; doi: 10.1097/00001756-200004070-00032
67.
ChauCH, ShumDK, LiH, et al.Chondroitinase ABC enhances axonal regrowth through Schwann cell-seeded guidance channels after spinal cord injury. Faseb J, 2004; 18(1):194–196; doi: 10.1096/fj.03-0196fje
68.
FouadK, SchnellL, BungeMB, et al.Combining Schwann cell bridges and olfactory-ensheathing glia grafts with chondroitinase promotes locomotor recovery after complete transection of the spinal cord. J Neurosci, 2005; 25(5):1169–1178; doi: 10.1523/JNEUROSCI.3562-04.2005
69.
DePaulMA, LinCY, SilverJ, et al.Combinatory repair strategy to promote axon regeneration and functional recovery after chronic spinal cord injury. Sci Rep, 2017; 7(1):9018; doi: 10.1038/s41598-017-09432-6
70.
YokotaK, FehlingsMG. Acidic fibroblast growth factor in spinal cord injury: A potential therapy which merits further investigation. Neurospine, 2019; 16(4):739–741; doi: 10.14245/ns.19edi.018
71.
ZhouY, WangZ, LiJ, et al.Fibroblast growth factors in the management of spinal cord injury. J Cell Mol Med, 2018; 22(1):25–37; doi: 10.1111/jcmm.13353
72.
DengLX, WalkerC, XuXM. Schwann cell transplantation and descending propriospinal regeneration after spinal cord injury. Brain Res, 2015; 1619:104–114; doi: 10.1016/j.brainres.2014.09.038
73.
AlilainWJ, HornKP, HuH, et al.Functional regeneration of respiratory pathways after spinal cord injury. Nature, 2011; 475(7355):196–200; doi: 10.1038/nature10199
74.
BowesC, MasseyJM, BurishM, et al.Chondroitinase ABC promotes selective reactivation of somatosensory cortex in squirrel monkeys after a cervical dorsal column lesion. Proc Natl Acad Sci U S A, 2012; 109(7):2595–2600; doi: 10.1073/pnas.1121604109
75.
RosenzweigES, SalegioEA, LiangJJ, et al.Chondroitinase improves anatomical and functional outcomes after primate spinal cord injury. Nat Neurosci, 2019; 22(8):1269–1275; doi: 10.1038/s41593-019-0424-1
BungeMB. Efficacy of Schwann cell transplantation for spinal cord repair is improved with combinatorial strategies. J Physiol, 2016; 594(13):3533–3538; doi: 10.1113/JP271531
78.
NicholasTHR, DanielsonJ. First human implantation of a bioresorbable polymer scaffold for acute traumatic spinal cord injury: A clinical pilot study for safety and feasibility. 2016.
79.
SantamariaAJ, SolanoJP, BenavidesFD, et al.Intraspinal delivery of schwann cells for spinal cord injury. Methods Mol Biol, 2018; 1739:467–484; doi: 10.1007/978-1-4939-7649-2_31
80.
HettiaratchiMH, O’MearaMJ, O’MearaTR, et al.Reengineering biocatalysts: Computational redesign of chondroitinase ABC improves efficacy and stability. Sci Adv, 2020; 6(34):eabc6378; doi: 10.1126/sciadv.abc6378
81.
Letko KhaitN, ZuccaroS, AbdoD, et al.Redesigned chondroitinase ABC degrades inhibitory chondroitin sulfate proteoglycans in vitro and in vivo in the stroke-injured rat brain. Biomaterials, 2025; 314:122818; doi: 10.1016/j.biomaterials.2024.122818
82.
LangBT, CreggJM, DePaulMA, et al.Modulation of the proteoglycan receptor PTPsigma promotes recovery after spinal cord injury. Nature, 2015; 518(7539):404–408; doi: 10.1038/nature13974
83.
ZavvarianMM, ToossiA, KhazaeiM, et al.Novel innovations in cell and gene therapies for spinal cord injury. F1000Res, 2020; 9:F1000 Faculty Rev–F1000 Faculty 279; doi: 10.12688/f1000research.21989.1
84.
BlitsB, BungeMB. Direct gene therapy for repair of the spinal cord. J Neurotrauma, 2006; 23(3–4):508–520.
AndersonMA, O’SheaTM, BurdaJE, et al.Required growth facilitators propel axon regeneration across complete spinal cord injury. Nature, 2018; 561(7723):396–400; doi: 10.1038/s41586-018-0467-6
88.
JinY, TesslerA, FischerI, et al.Fibroblasts genetically modified to produce BDNF support regrowth of chronically injured serotonergic axons. Neurorehabil Neural Repair, 2000; 14(4):311–317; doi: 10.1177/154596830001400407
89.
AngeliCA, BoakyeM, MortonRA, et al.Recovery of over-ground walking after chronic motor complete spinal cord injury. N Engl J Med, 2018; 379(13):1244–1250; doi: 10.1056/NEJMoa1803588
90.
LavrovI, DyCJ, FongAJ, et al.Epidural stimulation induced modulation of spinal locomotor networks in adult spinal rats. J Neurosci, 2008; 28(23):6022–6029; doi: 10.1523/JNEUROSCI.0080-08.2008
91.
CourtineG, GerasimenkoY, van den BrandR, et al.Transformation of nonfunctional spinal circuits into functional states after the loss of brain input. Nat Neurosci, 2009; 12(10):1333–1342; doi: 10.1038/nn.2401
92.
McHughLV, MillerAA, LeechKA, et al.Feasibility and utility of transcutaneous spinal cord stimulation combined with walking-based therapy for people with motor incomplete spinal cord injury. Spinal Cord Ser Cases, 2020; 6(1):104; doi: 10.1038/s41394-020-00359-1
93.
BloomO, WechtJM, Legg DitterlineBE, et al.Prolonged targeted cardiovascular epidural stimulation improves immunological molecular profile: A case report in chronic severe spinal cord injury. Front Syst Neurosci, 2020; 14:571011; doi: 10.3389/fnsys.2020.571011
94.
BroseSW, BourbeauDJ, GustafsonKJ. Genital nerve stimulation is tolerable and effective for bladder inhibition in sensate individuals with incomplete SCI. J Spinal Cord Med, 2018; 41(2):174–181; doi: 10.1080/10790268.2017.1279817
95.
PoslusznyJAJr, OndersR, KerwinAJ, et al.Multicenter review of diaphragm pacing in spinal cord injury: Successful not only in weaning from ventilators but also in bridging to independent respiration. J Trauma Acute Care Surg, 2014; 76(2):303–309; discussion 309-10; doi: 10.1097/TA.0000000000000112
96.
HayesHB, JayaramanA, HerrmannM, et al.Daily intermittent hypoxia enhances walking after chronic spinal cord injury: A randomized trial. Neurology, 2014; 82(2):104–113; doi: 10.1212/01.WNL.0000437416.34298.43
EdgertonVR, HarkemaS. Epidural stimulation of the spinal cord in spinal cord injury: Current status and future challenges. Expert Rev Neurother, 2011; 11(10):1351–1353; doi: 10.1586/ern.11.129
99.
MayrW, KrennM, DimitrijevicMR. Epidural and transcutaneous spinal electrical stimulation for restoration of movement after incomplete and complete spinal cord injury. Curr Opin Neurol, 2016; 29(6):721–726; doi: 10.1097/WCO.0000000000000382
100.
Gonzalez-RothiEJ, StreeterKA, HannaMH, et al.High-frequency epidural stimulation across the respiratory cycle evokes phrenic short-term potentiation after incomplete cervical spinal cord injury. J Neurophysiol, 2017; 118(4):2344–2357; doi: 10.1152/jn.00913.2016
101.
LuscherC, MalenkaRC. NMDA receptor-dependent long-term potentiation and long-term depression (LTP/LTD). Cold Spring Harb Perspect Biol, 2012; 4(6):a005710; doi: 10.1101/cshperspect.a005710
102.
KatheC, SkinniderMA, HutsonTH, et al.The neurons that restore walking after paralysis. Nature, 2022; 611(7936):540–547; doi: 10.1038/s41586-022-05385-7
103.
DobleA. The pharmacology and mechanism of action of riluzole. Neurology, 1996; 47(6 Suppl 4):S233–S41; doi: 10.1212/wnl.47.6_suppl_4.233s
104.
BaptisteDC, FehlingsMG. Pharmacological approaches to repair the injured spinal cord. J Neurotrauma, 2006; 23(3–4):318–334; doi: 10.1089/neu.2006.23.318
105.
FehlingsMG, WilsonJR, FrankowskiRF, et al.Riluzole for the treatment of acute traumatic spinal cord injury: Rationale for and design of the NACTN Phase I clinical trial. J Neurosurg Spine, 2012; 17(Suppl 1):151–156; doi: 10.3171/2012.4.AOSPINE1259
106.
FehlingsMG, MoghaddamjouA, HarropJS, et al.Safety and efficacy of Riluzole in Acute Spinal Cord Injury Study (RISCIS): A multi-center, randomized, placebo-controlled, double-blinded trial. J Neurotrauma, 2023; 40(17–18):1878–1888; doi: 10.1089/neu.2023.0163
107.
ChowDS, NguyenA, ParkJ, et al.Riluzole in Spinal Cord Injury Study (RISCIS)-Pharmacokinetic (PK) sub-study: An analysis of pharmacokinetics, pharmacodynamics, and impact on axonal degradation of Riluzole in patients with traumatic cervical spinal cord injury enrolled in the RISCIS phase III randomized controlled trial. J Neurotrauma, 2023; 40(17–18):1889–1906; doi: 10.1089/neu.2022.0499
108.
GrossmanRG, FehlingsMG, FrankowskiRF, et al.A prospective, multicenter, phase I matched-comparison group trial of safety, pharmacokinetics, and preliminary efficacy of riluzole in patients with traumatic spinal cord injury. J Neurotrauma, 2014; 31(3):239–255; doi: 10.1089/neu.2013.2969
109.
CashaS, ZygunD, McGowanMD, et al.Results of a phase II placebo-controlled randomized trial of minocycline in acute spinal cord injury. Brain, 2012; 135(Pt 4):1224–1236; doi: 10.1093/brain/aws072
110.
UlndreajA, BadnerA, FehlingsMG. Promising neuroprotective strategies for traumatic spinal cord injury with a focus on the differential effects among anatomical levels of injury. F1000Res, 2017; 6:1907; doi: 10.12688/f1000research.11633.1
111.
WilsonTK, TrippJ. Buspirone. In: StatPearls. Treasure Island (FL); 2020.
112.
HachemLD, MotheAJ, TatorCH. Evaluation of the effects of riluzole on adult spinal cord-derived neural stem/progenitor cells in vitro and in vivo. Int J Dev Neurosci, 2015; 47(Pt B):140–146; doi: 10.1016/j.ijdevneu.2015.08.007
113.
NogradiA, VrbovaG. The effect of riluzole treatment in rats on the survival of injured adult and grafted embryonic motoneurons. Eur J of Neuroscience, 2001; 13(1):113–118; doi: 10.1046/j.0953-816x.2000.01362.x
114.
KhazaeiM, AhujaCS, NakashimaH, et al.GDNF rescues the fate of neural progenitor grafts by attenuating Notch signals in the injured spinal cord in rodents. Sci Transl Med, 2020; 12(525):eaau3538; doi: 10.1126/scitranslmed.aau3538
115.
BregmanBS, CoumansJV, DaiHN, et al.Transplants and neurotrophic factors increase regeneration and recovery of function after spinal cord injury. Prog Brain Res, 2002; 137:257–273; doi: 10.1016/s0079-6123(02)37020-1
116.
RobinsonJ, LuP. Optimization of trophic support for neural stem cell grafts in sites of spinal cord injury. Exp Neurol, 2017; 291:87–97; doi: 10.1016/j.expneurol.2017.02.007
117.
FehlingsMG, VaccaroA, WilsonJR, et al.Early versus delayed decompression for traumatic cervical spinal cord injury: Results of the Surgical Timing in Acute Spinal Cord Injury Study (STASCIS). PLoS One, 2012; 7(2):e32037; doi: 10.1371/journal.pone.0032037
118.
WilsonJR, TetreaultLA, KwonBK, et al.Timing of decompression in patients with acute spinal cord injury: A systematic review. Global Spine J, 2017; 7(Suppl 3):95S–115S; doi: 10.1177/2192568217701716
119.
BadhiwalaJH, WilsonJR, WitiwCD, et al.The influence of timing of surgical decompression for acute spinal cord injury: A pooled analysis of individual patient data. Lancet Neurol, 2021; 20(2):117–126; doi: 10.1016/S1474-4422(20)30406-3
120.
BerlowitzDJ, WadsworthB, RossJ. Respiratory problems and management in people with spinal cord injury. Breathe (Sheff), 2016; 12(4):328–340; doi: 10.1183/20734735.012616
121.
BazarekS, BrownJM. The evolution of nerve transfers for spinal cord injury. Exp Neurol, 2020; 333:113426; doi: 10.1016/j.expneurol.2020.113426
122.
DididzeM, GreenBA, DietrichWD, et al.Systemic hypothermia in acute cervical spinal cord injury: A case-controlled study. Spinal Cord, 2013; 51(5):395–400; doi: 10.1038/sc.2012.161
123.
ChatzipanteliK, YanagawaY, MarcilloAE, et al.Posttraumatic hypothermia reduces polymorphonuclear leukocyte accumulation following spinal cord injury in rats. J Neurotrauma, 2000; 17(4):321–332; doi: 10.1089/neu.2000.17.321
124.
ChaoK, BurnsTC, BoakyeM and FehlingsMG. Breakthroughs of the last twenty years. In: Essentials of Spinal Cord Injury. (FehlingsMG. ed.) Thieme Medical Publishers, Inc.: New York, NY; 2013.
125.
AntoniosJP, FarahGJ, ClearyDR, et al.Immunosuppressive mechanisms for stem cell transplant survival in spinal cord injury. Neurosurg Focus, 2019; 46(3):E9; doi: 10.3171/2018.12.FOCUS18589
126.
KofflerJ, ZhuW, QuX, et al.Biomimetic 3D-printed scaffolds for spinal cord injury repair. Nat Med, 2019; 25(2):263–269; doi: 10.1038/s41591-018-0296-z
127.
TheodoreN, HlubekR, DanielsonJ, et al.First human implantation of a bioresorbable polymer scaffold for acute traumatic spinal cord injury: A clinical pilot study for safety and feasibility. Neurosurgery, 2016; 79(2):E305–E12; doi: 10.1227/NEU.0000000000001283
128.
HakimJS, RodysillBR, ChenBK, et al.Combinatorial tissue engineering partially restores function after spinal cord injury. J Tissue Eng Regen Med, 2019; 13(5):857–873; doi: 10.1002/term.2840
129.
YangEZ, ZhangGW, XuJG, et al.Multichannel polymer scaffold seeded with activated Schwann cells and bone mesenchymal stem cells improves axonal regeneration and functional recovery after rat spinal cord injury. Acta Pharmacol Sin, 2017; 38(5):623–637; doi: 10.1038/aps.2017.11
130.
OlsonHE, RooneyGE, GrossL, et al.Neural stem cell- and Schwann cell-loaded biodegradable polymer scaffolds support axonal regeneration in the transected spinal cord. Tissue Eng Part A, 2009; 15(7):1797–1805; doi: 10.1089/ten.tea.2008.0364
131.
WangJ, ZhengW, ChenL, ZhuT, et al.Enhancement of Schwann Cells Function Using Graphene-Oxide-Modified Nanofiber Scaffolds for Peripheral Nerve Regeneration. ACS Publication; 2019.
132.
HallAA, FortinoTA, SpruanceVM, et al.Cell transplatation to repair the injured spinal cord. In: Current Challenges in Cell Therapy for Neurodegenerative Diseases. (LaneE, DrewC, LelosM eds.) Academic Press: 2022.
133.
YangY, PangM, DuC, et al.Repeated subarachnoid administrations of allogeneic human umbilical cord mesenchymal stem cells for spinal cord injury: A phase 1/2 pilot study. Cytotherapy, 2021; 23(1):57–64; doi: 10.1016/j.jcyt.2020.09.012
134.
ZholudevaLV, LaneMA. Transplanting cells for spinal cord repair: Who, what, when, where and why? Cell Transplant, 2019; 28(4):388–399; doi: 10.1177/0963689718824097
135.
TsujiO, SugaiK, YamaguchiR, et al.Concise review: Laying the groundwork for a first-in-human study of an induced pluripotent stem cell-based intervention for spinal cord injury. Stem Cells, 2019; 37(1):6–13; doi: 10.1002/stem.2926
136.
LujanHL, DiCarloSE. Direct comparison of cervical and high thoracic spinal cord injury reveals distinct autonomic and cardiovascular consequences. J Appl Physiol (1985), 2020; 128(3):554–564; doi: 10.1152/japplphysiol.00721.2019
137.
Biering-SorensenF, AlaiS, AndersonK, et al.Common data elements for spinal cord injury clinical research: A National Institute for Neurological Disorders and Stroke project. Spinal Cord, 2015; 53(4):265–277; doi: 10.1038/sc.2014.246
138.
LeenaarsCHC, KouwenaarC, StafleuFR, et al.Animal to human translation: A systematic scoping review of reported concordance rates. J Transl Med, 2019; 17(1):223; doi: 10.1186/s12967-019-1976-2
139.
WarrenPM, SteigerSC, DickTE, et al.Rapid and robust restoration of breathing long after spinal cord injury. Nat Commun, 2018; 9(1):4843; doi: 10.1038/s41467-018-06937-0
140.
BrownA, WeaverLC. The dark side of neuroplasticity. Exp Neurol, 2012; 235(1):133–141; doi: 10.1016/j.expneurol.2011.11.004
141.
MoherD, DulbergCS, WellsGA. Statistical power, sample size, and their reporting in randomized controlled trials. JAMA, 1994; 272(2):122–124.
142.
Strategies to Leverage Research Funding: Guiding DOD’s Peer Reviewed Medical Research Programs. (McGearyM, HannaKE, eds.) The National Academies Press: Washington (DC); 2004.
143.
NSCISC. Traumatic spinal cord injury facts and figures at a glance. J Spinal Cord Med, 2023; 36(1):1–2.
144.
StraussDJ, DevivoMJ, PaculdoDR, et al.Trends in life expectancy after spinal cord injury. Arch Phys Med Rehabil, 2006; 87(8):1079–1085.
145.
van den BergME, CastelloteJM, Mahillo-FernandezI, et al.Incidence of spinal cord injury worldwide: A systematic review. Neuroepidemiology, 2010; 34(3):184–192; discussion 192; doi: 10.1159/000279335
146.
KhouryMJ, GwinnM, IoannidisJP. The emergence of translational epidemiology: From scientific discovery to population health impact. Am J Epidemiol, 2010; 172(5):517–524; doi: 10.1093/aje/kwq211
147.
LasfarguesJE, CustisD, MorroneF, et al.A model for estimating spinal cord injury prevalence in the United States. Paraplegia, 1995; 33(2):62–68; doi: 10.1038/sc.1995.16
148.
KumarR, LimJ, MekaryRA, et al.Traumatic spinal injury: Global epidemiology and worldwide volume. World Neurosurg, 2018; 113:e345–e363; doi: 10.1016/j.wneu.2018.02.033
149.
GuanB, AndersonDB, ChenL, et al.Global, regional and national burden of traumatic brain injury and spinal cord injury, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019. BMJ Open, 2023; 13(10):e075049; doi: 10.1136/bmjopen-2023-075049
150.
SinghA, TetreaultL, Kalsi-RyanS, et al.Global prevalence and incidence of traumatic spinal cord injury. Clin Epidemiol, 2014; 6:309–331; doi: 10.2147/CLEP.S68889
